Ignite Creation Date:
2025-12-24 @ 12:37 PM
Ignite Modification Date:
2026-03-01 @ 6:00 AM
Study NCT ID:
NCT04423861
Status:
UNKNOWN
Last Update Posted:
2022-10-31
First Post:
2020-06-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19
Sponsor:
Azidus Brasil
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NITFQM0920OR-III
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |